Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing SpectrumAnn Neurol 87:659-669, Dubey, D.,et al, 2020
Neuromuscular Adverse Events Associated with Anti-PD-1 Monoclonal AntibodiesNeurol 92:663-674, Johansen, A.,et al, 2019